Featured Press Releases

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Carterra unveils Carterra Ultra™, its most sensitive biosensor platform, advancing fragment and small molecule drug discovery

Carterra unveils Carterra Ultra™, its most sensitive biosensor platform, advancing fragment and small molecule drug discovery

  • 04 Sep 2024

Carterra Inc., the world leader in innovative technologies enabling high-throughput biology, today has...

Great Bay Bio launches its Intelligent Drug Development Ecosystem

Great Bay Bio launches its Intelligent Drug Development Ecosystem

Artax Biopharma validates AX-158, a first-in-class oral Nck modulator, in phase 2a for autoimmune disease

Artax Biopharma validates AX-158, a first-in-class oral Nck modulator, in phase 2a for autoimmune disease

Vector Laboratories Appoints Ashley Scholz as Vice President of Marketing

Vector Laboratories Appoints Ashley Scholz as Vice President of Marketing

Key Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial Reported by Blue Earth Therapeutics

Key Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial Reported by Blue Earth Therapeutics

Developing innovative production technology for the commercialization of 3D cell products, PHC and Cyfuse collaborate

Developing innovative production technology for the commercialization of 3D cell products, PHC and Cyfuse collaborate

  • PHC Corporation
  • 20 Mar 2025
Marking a new era of uncovering the potential of NAD+ with precision science, ChromaDex evolves into Niagen Bioscience

Marking a new era of uncovering the potential of NAD+ with precision science, ChromaDex evolves into Niagen Bioscience

  • Niagen Bioscience
  • 19 Mar 2025
Medit introduces SmartX, a new All-on-X solution for digital dentistry

Medit introduces SmartX, a new All-on-X solution for digital dentistry

  • Medit
  • 18 Mar 2025
Actinium Pharmaceuticals publishes Actimab-A + CLAG-M trial results for relapsed/refractory AML in Leukemia

Actinium Pharmaceuticals publishes Actimab-A + CLAG-M trial results for relapsed/refractory AML in Leukemia

  • Actinium Pharmaceuticals, Inc
  • 17 Mar 2025
Applications Are Being Accepted by the Vilcek Foundation from Immigrants Working in Biomedical Science

Applications Are Being Accepted by the Vilcek Foundation from Immigrants Working in Biomedical Science

  • The Vilcek Foundation
  • 17 Mar 2025
Key Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial Reported by Blue Earth Therapeutics

Key Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial Reported by Blue Earth Therapeutics

  • Blue Earth Therapeutics Ltd
  • 13 Mar 2025
12th Annual PANAGORA Pharma CX Summit 2025

Most Popular
March   2025
M T W T F S S
          1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31            

User Area

Discover

Engage with Us

© 2024 Pharmaceutical Era — A product of HISSM. All Rights Reserved.